Lung Cancer Biomarker Testing Insurance Coverage, Advocacy & Lived Experience

Upcoming Webinar: Lung Cancer Biomarker Testing Join us on May 19, 2026 | 4:00–5:00 PM ET for a live ECHO bonus webinar exploring lung cancer biomarker testing, insurance coverage, and patient advocacy. Hear from clinical experts, policy leaders, and patient advocates on why access to testing matters—and how you can make a difference.

Promoting Guideline Concordant Staging Video Series

A new six-part video series designed to help patients and their families become more knowledgeable partners in decisions around nodal staging.

2026 ACS NLCRT National Meeting

Save the Date! The 10th ACS NLCRT National Meeting on December 7th and 8th. (location to be determined and shared soon!)

ACS NLCRT Chair Dr. Ella Kazerooni receives ACS Volunteer Leadership Award

This is the highest recognition given to ACS volunteers, awarded annually to up to two individuals for exceptional leadership and long-standing service to enterprise-wide programs, initiatives, Board level committees, or task forces.

Strategic Plan Article Series

The first nine articles in the ACS NLCRT Strategic Plan Article Series are available in open access in Cancer.

Our Mission

Our mission is to create lung cancer survivors.

By the Numbers

Lung cancer is the second most commonly diagnosed cancer in both men and women but the most common cause of cancer death, leading to more deaths in 2020 than breast, colorectal, and prostate cancers combined.

238,340


Estimated New Cases for 2023

127,070


Estimated Deaths for 2023

56.3%


Incidence Rate (2015-2019)

35.0%


Mortality Rate (2016-2020)

Resource Center

We have a wealth of resources created by our incredible task groups as well as other organizations working to end lung cancer death.

ACS NLCRT 8th Annual Meeting Executive Summary

December 9-10, 2024

The 8th ACS NLCRT Annual Meeting was held December 9-10, 2024 in Atlanta, GA.

Task Groups

Our 10 task groups span the lung cancer care and control continuum.

Initiatives focus on provider engagement and outreach, tobacco treatment in the context of lung cancer screening, health equity, shared decision-making about screening, implementation of screening programs, access to high quality screening, policy action, survivorship, triage for appropriate diagnostic evaluation and therapy, and an end to the stigma and nihilism associated with a diagnosis of lung cancer, which pervades every aspect of this disease.

Two women discussing behind a laptop.

Sign Up for ACS National Lung Cancer Roundtable Emails

Stay up to date with the latest ACS NLCRT news.

Name(Required)

Other ACS Led Roundtables

The American Cancer Society serves as the backbone to six mission-critical national roundtables. Click on the logos below to explore more about each roundtable.